Cargando…

From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation

Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some di...

Descripción completa

Detalles Bibliográficos
Autores principales: Stranger, Barbara E, Dermitzakis, Emmanouil T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525162/
https://www.ncbi.nlm.nih.gov/pubmed/16848976
http://dx.doi.org/10.1186/1479-7364-2-6-383
_version_ 1782253402133102592
author Stranger, Barbara E
Dermitzakis, Emmanouil T
author_facet Stranger, Barbara E
Dermitzakis, Emmanouil T
author_sort Stranger, Barbara E
collection PubMed
description Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some diseases with a genetic basis are caused by nucleotide changes that alter an amino acid sequence, in other cases, disease risk is associated with altered gene regulation. This paper focuses on how studies of gene expression variation might complement disease studies and provide crucial links between genotype and phenotype.
format Online
Article
Text
id pubmed-3525162
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35251622012-12-19 From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation Stranger, Barbara E Dermitzakis, Emmanouil T Hum Genomics Review Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some diseases with a genetic basis are caused by nucleotide changes that alter an amino acid sequence, in other cases, disease risk is associated with altered gene regulation. This paper focuses on how studies of gene expression variation might complement disease studies and provide crucial links between genotype and phenotype. BioMed Central 2006-06-01 /pmc/articles/PMC3525162/ /pubmed/16848976 http://dx.doi.org/10.1186/1479-7364-2-6-383 Text en Copyright ©2006 Henry Stewart Publications
spellingShingle Review
Stranger, Barbara E
Dermitzakis, Emmanouil T
From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
title From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
title_full From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
title_fullStr From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
title_full_unstemmed From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
title_short From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
title_sort from dna to rna to disease and back: the 'central dogma' of regulatory disease variation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525162/
https://www.ncbi.nlm.nih.gov/pubmed/16848976
http://dx.doi.org/10.1186/1479-7364-2-6-383
work_keys_str_mv AT strangerbarbarae fromdnatornatodiseaseandbackthecentraldogmaofregulatorydiseasevariation
AT dermitzakisemmanouilt fromdnatornatodiseaseandbackthecentraldogmaofregulatorydiseasevariation